For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2024-09-30 |
|---|---|---|---|---|
| Revenues | 0 | 0 | 0 | - |
| Cost of revenues | 0 | 0 | 0 | - |
| Gross profit | 0 | 0 | 0 | - |
| Research and development | 541,658 | 465,154 | 501,261 | 581,796 |
| Selling, general and administrative | 888,640 | 776,821 | 731,517 | 498,607 |
| Amortization of patent costs | 28,855 | 31,059 | 30,742 | 29,271 |
| Total expenses | 1,459,153 | 1,273,034 | 1,263,520 | 1,109,674 |
| Operating loss | -1,459,153 | -1,273,034 | -1,263,520 | -1,109,674 |
| Interest income | 55,436 | 37,100 | 30,217 | 69,539 |
| Total other income | 55,436 | 37,100 | 30,217 | 69,539 |
| Loss before provision for income taxes | -1,403,717 | -1,235,934 | -1,233,303 | -1,040,135 |
| Provision for income taxes | 0 | 0 | 0 | - |
| Net loss | -1,403,717 | - | - | - |
| Net income attributable to non-controlling interest | 1,360 | - | - | - |
| Net loss attributable to cmth | -1,405,077 | -1,235,934 | -1,233,303 | -1,040,135 |
| Diluted EPS | -0.38 | -0.48 | -0.48 | - |
| Diluted Average Shares | 3,701,668 | 2,580,532 | 2,580,532 | - |
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)